These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 17002668

  • 1. Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent.
    Harirforoosh S, Aghazadeh-Habashi A, Jamali F.
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):917-24. PubMed ID: 17002668
    [Abstract] [Full Text] [Related]

  • 2. Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam.
    Harirforoosh S, Jamali F.
    J Appl Toxicol; 2008 Oct; 28(7):829-38. PubMed ID: 18344196
    [Abstract] [Full Text] [Related]

  • 3. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G, Bilò MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadonna P, Dama AR.
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [Abstract] [Full Text] [Related]

  • 4. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].
    Valat JP, Deray G, Héloire F.
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S25-34. PubMed ID: 17078592
    [Abstract] [Full Text] [Related]

  • 5. Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat.
    Harirforoosh S, Jamali F.
    Can J Physiol Pharmacol; 2005 Jan; 83(1):85-90. PubMed ID: 15759054
    [Abstract] [Full Text] [Related]

  • 6. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
    Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K.
    Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2.
    Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA.
    FASEB J; 2006 Mar; 20(3):542-4. PubMed ID: 16403783
    [Abstract] [Full Text] [Related]

  • 12. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
    Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J.
    Drug Saf; 2006 Mar; 29(7):621-32. PubMed ID: 16808554
    [Abstract] [Full Text] [Related]

  • 13. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A, Boisseau M, Yusup A, Upur H, Bégaud B, Moore N.
    Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377
    [Abstract] [Full Text] [Related]

  • 14. Covalent binding of radioactivity from [14C]rofecoxib, but not [14C]celecoxib or [14C]CS-706, to the arterial elastin of rats.
    Oitate M, Hirota T, Koyama K, Inoue S, Kawai K, Ikeda T.
    Drug Metab Dispos; 2006 Aug; 34(8):1417-22. PubMed ID: 16679386
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA.
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [Abstract] [Full Text] [Related]

  • 16. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z.
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [Abstract] [Full Text] [Related]

  • 17. Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.
    Huledal G, Jonzon B, Malmenäs M, Hedman A, Andersson LI, Odlind B, Brater DC.
    Clin Pharmacol Ther; 2005 May; 77(5):437-50. PubMed ID: 15900289
    [Abstract] [Full Text] [Related]

  • 18. Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors.
    Micklewright R, Lane S, Linley W, McQuade C, Thompson F, Maskrey N.
    Aliment Pharmacol Ther; 2003 Feb; 17(3):321-32. PubMed ID: 12562444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs.
    MacDonald TM, Morant SV, Goldstein JL, Burke TA, Pettitt D.
    Gut; 2003 Sep; 52(9):1265-70. PubMed ID: 12912856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.